Cyber-attack cost Merck $135m in lost sales

Pharmaceutical giant Merck & Co says a recent cyber-attack resulted in production shutdowns and cost it around $135m in lost revenue.

Merck – known as MSD outside North America – said the attack had a particular impact on its ability to supply its human papillomavirus (HPV) vaccine Gardasil, used to prevent cervical and related cancers. The cost of implementing remediation measures in the wake of the attack also pegged back its gross margin in the third quarter.